These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8845036)

  • 21. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    Infect Immun; 1997 Apr; 65(4):1387-94. PubMed ID: 9119478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of female genital tract antibody responses by local or central (common) mucosal immunization.
    Wu HY; Abdu S; Stinson D; Russell MW
    Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.
    Saha A; Chowdhury MI; Nazim M; Alam MM; Ahmed T; Hossain MB; Hore SK; Sultana GN; Svennerholm AM; Qadri F
    Vaccine; 2013 Jan; 31(4):647-52. PubMed ID: 23200936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease.
    Jertborn M; Svennerholm AM; Holmgren J
    Int Arch Allergy Appl Immunol; 1988; 85(3):358-63. PubMed ID: 3350611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.
    Alam MM; Leung DT; Akhtar M; Nazim M; Akter S; Uddin T; Khanam F; Mahbuba DA; Ahmad SM; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    Clin Vaccine Immunol; 2013 Oct; 20(10):1541-8. PubMed ID: 23925888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
    Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
    Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
    Gallichan WS; Rosenthal KL
    Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine.
    Wiedermann U; Hanson LA; Holmgren J; Kahu H; Dahlgren UI
    Infect Immun; 1993 Sep; 61(9):3952-7. PubMed ID: 8359917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
    Harrod T; Martin M; Russell MW
    Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial.
    Mottram L; Lundgren A; Svennerholm AM; Leach S
    Vaccine; 2020 Jan; 38(3):655-662. PubMed ID: 31703936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.
    Karlsen TH; Sommerfelt H; Klomstad S; Andersen PK; Strand TA; Ulvik RJ; Ahrén C; Grewal HM
    Infect Immun; 2003 Jul; 71(7):3909-13. PubMed ID: 12819076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.